ABVC BioPharma获得50，000美元增量许可费，股价攀升

2024-10-22 21:09

ABVC BioPharma (NASDAQ:ABVC) has secured an additional $50,000 in licensing fees from AiBtl BioPharma, it said on Tuesday, sending shares up in premarket trade.
ABVC (ABVC) shares rose +4.89% premarket to $0.57.
With this payment, ABVC has received a total of $346,000 in licensing fees from its strategic partners.
ABVC has received 23M AiBtl shares as part of the first milestone of the licensing fees and will obtain royalties up to $100M after the product launches.
Source: Press Release

More on ABVC BioPharma